Leave a Reply
NP/PA Bloggers
Elizabeth Donahue, RN, MSN, NP‑C
Alexandra Godfrey, BSc PT, MS PA‑C
Emily F. Moore, RN, MSN, CPNP‑PC, CCRN
Advanced practice clinicians treating patients in a variety of settings and specialties
Learn more about In Practice: Reflections from NPs and PAs.
NEJM — Recent Clinical Medicine Articles- The Hypertension Control Paradox — Why Is America Stuck? January 24, 2026Why is the United States failing to control the population’s blood pressure, despite the availability of well-understood, effective interventions? And what can health systems do to move the needle?
- Toxic Erythema of Chemotherapy January 24, 2026A 55-year-old woman with invasive ductal carcinoma presented with a rash that had developed after a round of chemotherapy and had worsened and spread to her axillae, groin, and popliteal fossae after several additional rounds.
- Medicare’s Role in Fighting Chronic Disease January 24, 2026The U.S. government can combat chronic disease among Medicare patients by strengthening primary care, expanding access to preventive care, making care more affordable, and modernizing Medicare benefits.
- The Hypertension Control Paradox — Why Is America Stuck? January 24, 2026
- NEJM — Recent Pediatrics Articles
- Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward January 22, 2026Autism research programs should focus on both causes and effective services and supports. Alarmist claims, chasing of debunked theories of causation, and further stigmatizing autism are counterproductive.
- Efgartigimod for Fetal Acetylcholine Receptor Antibody–Related Disorder January 22, 2026Use of off-label efgartigimod (a neonatal Fc receptor blocker) for fetal acetylcholine receptor antibody–related disorder during a pregnancy stabilized maternal antibodies and led to normal fetal development and a healthy birth.
- Cerebral Folate Deficiency, Autism, and the Role of Leucovorin January 21, 2026Recent FDA actions related to leucovorin have caused confusion. There is still a lack of scientific evidence establishing that the drug is a safe and effective treatment for autism.
- Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward January 22, 2026